This inventor holds 1 USPTO granted patent. Top assignees: Glaxo Group Limited, King's College London, Vanderbilt University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,170 
1 out of 196 
1 out of 1,221 
Years Active: 2019
Title: Helen Cox: Innovator in Melanocortin Receptor Modulation
Introduction
Helen Cox is a distinguished inventor based in London, GB. She has made significant contributions to the field of biochemistry, particularly in the development of positive allosteric modulators of the human melanocortin-4 receptor. Her innovative work has the potential to impact various therapeutic areas.
Latest Patents
Helen Cox holds a patent for "Positive allosteric modulators of human melanocortin-4 receptor." This patent discloses positive allosteric modulators of the melanocortin receptor and methods for utilizing these modulators. The patent showcases her expertise and commitment to advancing scientific knowledge.
Career Highlights
Throughout her career, Helen has worked with prestigious institutions such as Vanderbilt University and King's College London. Her experience in these renowned organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Helen has collaborated with notable colleagues, including Iain Tough and Lawrence A Wolfe. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Helen Cox is a remarkable inventor whose work on melanocortin receptor modulators exemplifies innovation in biochemistry. Her contributions continue to pave the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile